Default: Cancer Treatment Reviews

ISSN: 0305-7372

Journal Home

Journal Guideline

Cancer Treatment Reviews Q1 Unclaimed

W.B. Saunders Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Treatment Reviews is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 124. It has an SJR impact factor of 3,619 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

Cancer Treatment Reviews

3,619

SJR Impact factor

124

H Index

73

Total Docs (Last Year)

385

Total Docs (3 years)

6027

Total Refs

3421

Total Cites (3 years)

379

Citable Docs (3 years)

8,97

Cites/Doc (2 years)

82,56

Ref/Doc


Best articles

A new look at the original cases of Hodgkin's disease

View more

Adjuvant interferon-alpha in malignant melanoma: current status

View more

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer

View more

Assessment of response to systemic therapy focusing on metastatic bone disease

View more

Breast cancer risk following irradiation for Hodgkin's disease

View more

Chemotherapy in patients with metastatic or relapsed germ-cell tumours

View more

Clinical effectiveness of radiotherapy for Hodgkin's lymphoma: a summary .

View more

Clinical effectiveness of radiotherapy for non-Hodgkin's lymphoma: a summary

View more

Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review

View more

Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis

View more

Drug interactions with the taxanes: clinical implications

View more

Evidence-based oncology mitomycin C provides little additional benefit in the treatment of carcinoma of unknown primary site

View more
SHOW MORE ARTICLES

Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpoint

View more

Genetically modified tumour vaccines -where we are today

View more

Hereditary nonpolyposis colorectal cancer: preventive management

View more

Immunotherapy: the last 25 years

View more

Interleukin 2 (IL-2) therapy: potential advantages of locoregional versus systemic administration

View more

Letter to the editor

View more

Medulloblastoma in adults: clinical characteristics and treatment

View more

Oral antibiotic administration and early hospital discharge is a safe and effective alternative for treatment of low-risk neutropenic fever

View more

Paclitaxel plus cisplatin is as effective as regimens containing gemcitabine in people with advanced non-small cell lung cancer

View more

Photodynamic therapy significantly improves survival outcomes in people with non-resectable cholangiocarcinoma

View more

Pre-operative chemotherapy may improve survival for people with oesophageal cancer

View more

Primary chemotherapy or hormonotherapy for patients with breast cancer

View more

Comments

No comments ... Be the first to comment!